Cargando…

Emerging themes in idiopathic intracranial hypertension

PURPOSE: Idiopathic intracranial hypertension (IIH) is a rare disorder characterised by raised intracranial pressure. The underlying pathophysiology is mostly unknown and effective treatment is an unmet clinical need in this disease. This review evaluates key emerging themes regarding disease charac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grech, Olivia, Mollan, Susan P., Wakerley, Benjamin R., Alimajstorovic, Zerin, Lavery, Gareth G., Sinclair, Alexandra J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Neurological Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674362/ https://www.ncbi.nlm.nih.gov/pubmed/32700012 http://dx.doi.org/10.1007/s00415-020-10090-4

Ejemplares similares

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache
por: Grech, Olivia, et al.
Publicado: (2022)

Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
por: Mollan, S. P., et al.
Publicado: (2021)

Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
por: Grech, Olivia, et al.
Publicado: (2021)

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema
por: Mollan, Susan P., et al.
Publicado: (2021)

Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension
por: Mitchell, James L, et al.
Publicado: (2022)

Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
por: Westgate, Connar S.J., et al.
Publicado: (2021)

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
por: Mitchell, James L, et al.
Publicado: (2023)

Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)
por: Yiangou, Andreas, et al.
Publicado: (2021)

Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single-payer healthcare system
por: Elliot, Laura, et al.
Publicado: (2021)

Managing idiopathic intracranial hypertension in pregnancy: practical advice
por: Thaller, Mark, et al.
Publicado: (2022)

Idiopathic intracranial hypertension: consensus guidelines on management
por: Mollan, Susan P, et al.
Publicado: (2018)

Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial
por: Mollan, Susan P., et al.
Publicado: (2021)

Idiopathic intracranial hypertension: Evaluation of births and fertility through the Hospital Episode Statistics dataset
por: Thaller, Mark, et al.
Publicado: (2022)

Dysregulation of Amino Acid, Lipid, and Acylpyruvate Metabolism in Idiopathic Intracranial Hypertension: A Non-targeted Case Control and Longitudinal Metabolomic Study
por: Alimajstorovic, Zerin, et al.
Publicado: (2022)

The Role of Metabolism in Migraine Pathophysiology and Susceptibility
por: Grech, Olivia, et al.
Publicado: (2021)

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
por: Yiangou, Andreas, et al.
Publicado: (2020)

Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
por: Mollan, Susan P, et al.
Publicado: (2016)

What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals
por: Mollan, Susan, et al.
Publicado: (2019)

Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension
por: Mollan, Susan P., et al.
Publicado: (2022)

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol
por: Ottridge, Ryan, et al.
Publicado: (2017)

Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey
por: Scotton, William J, et al.
Publicado: (2018)

Advances in the understanding of headache in idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2019)

The Health Economic Evaluation of Bariatric Surgery Versus a Community Weight Management Intervention Analysis from the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT)
por: Aguiar, Magda, et al.
Publicado: (2021)

The expanding burden of idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2018)

Evaluation and management of adult idiopathic intracranial hypertension
por: Mollan, Susan P, et al.
Publicado: (2018)

11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
por: Hardy, Rowan S, et al.
Publicado: (2020)

Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
por: Westgate, Connar S J, et al.
Publicado: (2022)

Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
por: Mitchell, James L., et al.
Publicado: (2019)

11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
por: Markey, Keira, et al.
Publicado: (2020)

European Headache Federation guideline on idiopathic intracranial hypertension
por: Hoffmann, Jan, et al.
Publicado: (2018)

Determining the role of novel metabolic pathways in driving intracranial pressure reduction after weight loss
por: Alimajstorovic, Zerin, et al.
Publicado: (2023)

Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
por: Thaller, Mark, et al.
Publicado: (2021)

Headache determines quality of life in idiopathic intracranial hypertension
por: Mulla, Yasmeen, et al.
Publicado: (2015)

Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
por: Hornby, Catherine, et al.
Publicado: (2018)

Reviewing the Recent Developments in Idiopathic Intracranial Hypertension
por: Virdee, Jasvir, et al.
Publicado: (2020)

Alterations in metabolic flux in migraine and the translational relevance
por: Grech, Olivia, et al.
Publicado: (2022)

Idiopathic Intracranial Hypertension: Evaluation of Admissions and Emergency Readmissions through the Hospital Episode Statistic Dataset between 2002–2020
por: Mollan, Susan P., et al.
Publicado: (2021)

Evolving Evidence in Idiopathic Intracranial Hypertension
por: Mollan, Susan P., et al.
Publicado: (2021)

An Update on Imaging in Idiopathic Intracranial Hypertension
por: Moreno-Ajona, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5nunjqakenb3qbe1io8otassqf